(Q37670545)

21 August 2017

1 reference

title

Mechanisms of weight loss after gastric bypass and gastric banding (English)

1 reference

21 August 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

1

Marco Bueter

1 reference

14 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

Hutan Ashrafian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

publication date

17 August 2009

1 reference

21 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

page(s)

325-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

Central nervous system control of food intake

14 May 2020

cites work

1 reference

12 December 2020

Obesity in North America. An overview

1 reference

12 December 2020

Cholecystokinin and satiety: current perspectives

1 reference

12 December 2020

The public health impact of obesity

1 reference

12 December 2020

Effect of GLP-1 on lipid metabolism in human adipocytes.

1 reference

12 December 2020

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

12 December 2020

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

12 December 2020

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

12 December 2020

Ghrelin causes hyperphagia and obesity in rats.

1 reference

12 December 2020

Ghrelin enhances appetite and increases food intake in humans

1 reference

12 December 2020

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

12 December 2020

1 reference

12 December 2020

Incidence of deep venous thrombosis in patients undergoing obesity surgery.

1 reference

12 December 2020

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

12 December 2020

Food fails to suppress ghrelin levels in obese humans.

1 reference

12 December 2020

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

1 reference

12 December 2020

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

12 December 2020

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats.

1 reference

12 December 2020

Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

1 reference

12 December 2020

Explanations for weight loss after ileojejunal bypass in gross obesity

1 reference

12 December 2020

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

1 reference

12 December 2020

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

1 reference

12 December 2020

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

12 December 2020

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

12 December 2020

Lipolytic action of glucagon-like peptides in isolated rat adipocytes

1 reference

12 December 2020

Obesity and pharmacologic therapy

1 reference

12 December 2020

Obesity wars: molecular progress confronts an expanding epidemic

1 reference

12 December 2020

Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial

1 reference

12 December 2020

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

1 reference

12 December 2020

Physiology: does gut hormone PYY3-36 decrease food intake in rodents?

1 reference

12 December 2020

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

12 December 2020

Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects

1 reference

12 December 2020

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

1 reference

12 December 2020

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure

1 reference

12 December 2020

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

1 reference

12 December 2020

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

12 December 2020

On the physiology of GIP and GLP-1.

1 reference

12 December 2020

Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers

1 reference

12 December 2020

Meta-analysis: surgical treatment of obesity

1 reference

12 December 2020

Pharmacological therapies for obesity

1 reference

12 December 2020

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

1 reference

12 December 2020

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

12 December 2020

Ghrelin increases food intake in obese as well as lean subjects

1 reference

12 December 2020

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

1 reference

12 December 2020

Treatment of cachexia with ghrelin in patients with COPD.

1 reference

12 December 2020

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

12 December 2020

Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures

1 reference

12 December 2020

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

1 reference

12 December 2020

Effect of peptide YY3-36 on food intake in humans

1 reference

12 December 2020

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

12 December 2020

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

12 December 2020

Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons

1 reference

12 December 2020

Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity

1 reference

12 December 2020

Is gastrin partially responsible for body weight reduction after gastric bypass?

1 reference

12 December 2020

Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles

1 reference

12 December 2020

Cholecystokinin hyperresponsiveness in functional dyspepsia

1 reference

12 December 2020

Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer

1 reference

12 December 2020

Healthcare utilization and outcomes after bariatric surgery

1 reference

12 December 2020

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

1 reference

12 December 2020

Does ghrelin really matter after bariatric surgery?

1 reference

12 December 2020

In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes

1 reference

12 December 2020

Biology of incretins: GLP-1 and GIP

1 reference

12 December 2020

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

12 December 2020

Long-term mortality after gastric bypass surgery

1 reference

12 December 2020

Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice

1 reference

12 December 2020

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

1 reference

12 December 2020

Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?

1 reference

12 December 2020

Exenatide: its position in the treatment of type 2 diabetes

1 reference

12 December 2020

Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty

1 reference

12 December 2020

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

Cholecystokinin decreases sucrose intake in chronic decerebrate rats.

1 reference

12 December 2020

Peptides of the gut and brain: the cholecystokinins

1 reference

12 December 2020

Peptide YY abnormalities in gastrointestinal diseases

1 reference

12 December 2020

Morbid obesity--surgical treatment--when and how?

1 reference

12 December 2020

Human distribution and release of a putative new gut hormone, peptide YY

1 reference

12 December 2020

Cholecystokinin decreases food intake in rats.

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

12 December 2020

Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas

1 reference

12 December 2020

Effects of peptide YY and neuropeptide Y on gastric emptying in man

1 reference

12 December 2020

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

12 December 2020

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

12 December 2020

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

1 reference

12 December 2020

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

12 December 2020

A role for central glucagon-like peptide-1 in temperature regulation

1 reference

12 December 2020

Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide

1 reference

12 December 2020

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

12 December 2020

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

1 reference

12 December 2020

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex

1 reference

12 December 2020

Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes

1 reference

12 December 2020

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

12 December 2020

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

12 December 2020

Identifiers

DOI

10.1159/000232383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6515913&resulttype=core&format=json

14 May 2020

20057200

1 reference